These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17575471)

  • 21. [Pulmonary hypertension of the newborn--recent advances in the management and treatment].
    Vakrilova L; Radulova P; Hitrova S; Slancheva B
    Akush Ginekol (Sofiia); 2014; 53(4):50-8. PubMed ID: 25510072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future research directions in persistent pulmonary hypertension of the newborn.
    Soifer SJ; Heymann MA
    Clin Perinatol; 1984 Oct; 11(3):745-55. PubMed ID: 6386274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of iNO in the modulation of pulmonary vascular resistance.
    Bin-Nun A; Schreiber MD
    J Perinatol; 2008 Dec; 28 Suppl 3():S84-92. PubMed ID: 19057617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent pulmonary hypertension of the newborn.
    Thérèse P
    Paediatr Respir Rev; 2006; 7 Suppl 1():S175-6. PubMed ID: 16798554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice.
    Han RN; Stewart DJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):29-34. PubMed ID: 16387628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
    Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension.
    Tourneux P; Rakza T; Bouissou A; Krim G; Storme L
    J Pediatr; 2008 Sep; 153(3):345-9. PubMed ID: 18534241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models.
    Rieger-Fackeldey E; Hentschel R
    J Perinat Med; 2008; 36(5):442-7. PubMed ID: 18605970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infants with persistent pulmonary hypertension of the newborn.
    Hosono S; Ohno T; Kimoto H; Shimizu M; Takahashi S; Harada K
    J Perinat Med; 2006; 34(4):333-7. PubMed ID: 16856826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension.
    Christou H; Adatia I; Van Marter LJ; Kane JW; Thompson JE; Stark AR; Wessel DL; Kourembanas S
    J Pediatr; 1997 Apr; 130(4):603-11. PubMed ID: 9108859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in the pathogenesis and treatment of neonatal pulmonary hypertension.
    Abman SH
    Pediatr Pulmonol Suppl; 1999; 18():201-4. PubMed ID: 10093143
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistent pulmonary hypertension of the newborn with transposition of the great arteries.
    Roofthooft MT; Bergman KA; Waterbolk TW; Ebels T; Bartelds B; Berger RM
    Ann Thorac Surg; 2007 Apr; 83(4):1446-50. PubMed ID: 17383355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn.
    Distefano G; Sciacca P
    Ital J Pediatr; 2015 Feb; 41():6. PubMed ID: 25887340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide in the pulmonary vasculature.
    Coggins MP; Bloch KD
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1877-85. PubMed ID: 17541026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates.
    Poitras EL; Gust SL; Kerr PM; Plane F
    Curr Med Chem; 2021; 28(12):2418-2437. PubMed ID: 32964819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Nitric Oxide Pathway in Pulmonary Vascular Disease.
    Klinger JR; Kadowitz PJ
    Am J Cardiol; 2017 Oct; 120(8S):S71-S79. PubMed ID: 29025573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN) is in its infancy.
    Kissoon N
    J Crit Care; 2006 Jun; 21(2):223. PubMed ID: 16769472
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling.
    Sarkar S; Barks JD; Bhagat I; Dechert R; Donn SM
    Am J Perinatol; 2009 Apr; 26(4):265-70. PubMed ID: 19021092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
    Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
    Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.